In addition, the inhibition of EZH2 also sensitizes cancer cells to various other anti-cancer drugs such as HDAC inhibitors, imatinib, gemcitabine, paclitaxel, and cisplatin [66,67,68,69,70,71,72,73,74]. The gene discussed is HDAC9; the disease is cancer.